Sign In
Buy BIOVF
$47.48
+0 (+0%)
At Close: Jun 03, 2026
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q1 2026 Earnings Call Transcript
11:21am, Tuesday, 28'th Apr 2026
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q1 2026 Earnings Call Transcript
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
03:52am, Friday, 27'th Mar 2026
STOCKHOLM, March 27, 2026 /PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to b
Swedish Orphan Biovitrum AB (publ) (SWOBY) Analyst/Investor Day Transcript
06:24pm, Wednesday, 18'th Feb 2026
Swedish Orphan Biovitrum AB (publ) (SWOBY) Analyst/Investor Day Transcript
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q4 2025 Earnings Call Transcript
09:54am, Thursday, 05'th Feb 2026
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q4 2025 Earnings Call Transcript
Reviewing Swedish Orphan Biovitrum (OTCMKTS:BIOVF) & Astria Therapeutics (NASDAQ:ATXS)
03:10am, Sunday, 18'th Jan 2026
Swedish Orphan Biovitrum (OTCMKTS:BIOVF - Get Free Report) and Astria Therapeutics (NASDAQ: ATXS - Get Free Report) are both medical companies, but which is the superior business? We will compare the
Swedish Orphan Biovitrum AB (publ) (SWOBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
11:36pm, Tuesday, 13'th Jan 2026
Swedish Orphan Biovitrum AB (publ) (SWOBY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Swedish Orphan Biovitrum AB (publ) (SWOBY) M&A Call Transcript
07:59am, Monday, 15'th Dec 2025
Swedish Orphan Biovitrum AB (publ) (SWOBY) M&A Call Transcript
Swedish Orphan Biovitrum (OTCMKTS:BIOVF) Trading 1.1% Higher – What’s Next?
01:50am, Thursday, 04'th Dec 2025
Swedish Orphan Biovitrum (OTCMKTS:BIOVF - Get Free Report)'s share price was up 1.1% during trading on Wednesday. The stock traded as high as $35.25 and last traded at $35.25. Approximately 665 shares
Swedish Orphan Biovitrum AB (publ) (SWOBY) Q3 2025 Earnings Call Transcript
05:05pm, Monday, 20'th Oct 2025
Swedish Orphan Biovitrum AB (publ) (OTCPK:SWOBY) Q3 2025 Earnings Call October 20, 2025 7:00 AM EDT Company Participants Guido Oelkers - CEO & President Henrik Stenqvist - Chief Financial Officer Lydi
Swedish Orphan Biovitrum AB (publ) - Special Call
04:43pm, Tuesday, 16'th Sep 2025
Swedish Orphan Biovitrum AB (publ) - Special Call Company Participants Guido Oelkers - CEO & President Matthew Winfield Conference Call Participants Herbert S. B. Baraf Rehan Azeem Gonzalo Artiach Cas
Swedish Orphan Biovitrum AB (publ) (BIOVF) Q2 2025 Earnings Call Transcript
12:43pm, Wednesday, 16'th Jul 2025
Swedish Orphan Biovitrum AB (publ) (OTCPK:BIOVF) Q2 2025 Earnings Conference Call July 16, 2025 8:00 AM ET Company Participants Guido Oelkers - CEO & President Henrik Stenqvist - Chief Financial Offic
Swedish Orphan Biovitrum: Haematology Focus Seems To Be Paying Off
11:54pm, Wednesday, 21'st May 2025
BIOVF is moving from legacy products to a six-asset strategic portfolio that's mostly centered on Haematology. In particular, its Haematology segment contributed 71.6% of BIOVF's Q1 revenues, and five
Swedish Orphan Biovitrum AB (BIOVF) Q1 2025 Earnings Call Transcript
03:46pm, Tuesday, 29'th Apr 2025
Swedish Orphan Biovitrum AB (OTCPK:BIOVF) Q1 2025 Earnings Conference Call April 29, 2025 9:30 AM ET Company Participants Guido Oelkers - CEO Henrik Stenqvist - CFO Lydia Abad-Franch - Head, R&D and C
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
02:43am, Tuesday, 01'st Apr 2025
STOCKHOLM , April 1, 2025 /PRNewswire/ -- The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to
Swedish Orphan Biovitrum AB (publ) (BIOVF) Q4 2024 Earnings Call Transcript
08:07pm, Wednesday, 05'th Feb 2025
Swedish Orphan Biovitrum AB (publ) (OTCPK:BIOVF) Q4 2024 Earnings Conference Call February 5, 2025 8:30 AM ET Company Participants Guido Oelkers - Chief Executive Officer Henrik Stenqvist - Chief Fina
